Measurement uncertainty in microbiology.
Lynne I. Forster Training & Consulting Services, PO Box 15847, New Lynn, Auckland, New Zealand.Journal of AOAC International (Impact Factor: 1.12). 01/2003; 86(5):1089-94.
Testing laboratories wishing to comply with the requirements of ISO/IEC 17025:1999 need to estimate uncertainty of measurement for their quantitative methods. Many microbiological laboratories have had procedures available for monitoring variability in duplicate results generated by laboratory analysts for some time. These procedures, however, do not necessarily include all possible contributions to uncertainty in the calculations. Procedures for estimating microbiological method uncertainty, based on the Poisson distribution, have been published but, at times, the procedures can either underestimate uncertainty or require laboratories to undertake considerable experimental studies and more complex statistical calculations. This paper proposes procedures for estimating uncertainty of measurement in microbiology, whereby routine laboratory quality control data can be analyzed with simple statistical equations. The approaches used in these procedures are also applied to published data and examples, demonstrating that essentially equivalent results can be obtained with these procedures.
Full-text previewDOI: · Available from: dss.go.th
Data provided are for informational purposes only. Although carefully collected, accuracy cannot be guaranteed. The impact factor represents a rough estimation of the journal's impact factor and does not reflect the actual current impact factor. Publisher conditions are provided by RoMEO. Differing provisions from the publisher's actual policy or licence agreement may be applicable.
- [Show abstract] [Hide abstract]
ABSTRACT: Quantitative real-time PCR is one of the newer methods for measurement of the amount of nucleic material in biological systems. However, reliable measurement requires an appropriate estimation of uncertainty and this paper has developed the uncertainty budget associated with this procedure using as an example, data from a quantitative real-time PCR method for the enumeration of Campylobacter jejuni. This uncertainty is relatively large and for instance, a measured result of 151 units of DNA would have a 95% confidence interval of +/-84 units of DNA with the main sources of uncertainty being the measurement of the threshold cycle (Ct) value, the predicted DNA content of the unknown sample from the calibration line and the molar absorbance value for DNA.Journal of Microbiological Methods 12/2006; 67(2):349-56. DOI:10.1016/j.mimet.2006.04.005 · 2.03 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: The development of effective vaccines against zoonotic pathogens represents a priority in public health protection programs. The design of clinical trials and appropriate data analysis of the experiments results are crucial for the assessment of vaccine effectiveness. This manuscript reviews important issues related to the assessment of the effectiveness of vaccines designed to obtain a quantitative reduction of the pathogen in animals or animal products. An effective vaccine will reduce the risk of human infections and therefore the number of human cases. Important considerations will be illustrated using a vaccination trial of a new campylobacter vaccine candidate developed to reduce the numbers of campylobacter in chickens and consequently the numbers of human campylobacteriosis cases. The design of the author's vaccination trial was based on the use of isolators, a parallel group design and several rotations. The effect of clustering or design effect was considered in the sample size calculations. Chickens were randomly assigned to different isolators (treatments) and challenged with Campylobacter jejuni. Samples were obtained at different intervals and processed in the laboratory. C. jejuni counts were determined as colony-forming unit-per-gram of chicken cecum or fecal mass in order to assess vaccine effectiveness. A desired vaccine effect of 2 logs reduction on the numbers of C. jejuni recovered from vaccinated chickens was selected. Sample-size calculations, desired vaccine effect, biological and epidemiological aspects, experimental design and appropriate statistical analysis of data considering group or clustering effects will be the focus of this manuscript.Expert Review of Vaccines 10/2012; 11(10):1179-88. DOI:10.1586/erv.12.98 · 4.21 Impact Factor
- [Show abstract] [Hide abstract]
ABSTRACT: Leafy greens, including spinach, have potential for human norovirus transmission through improper handling and/or contact with contaminated water. Inactivation of norovirus prior to consumption is essential to protect public health. Because of the inability to propagate human noroviruses in vitro, murine norovirus (MNV-1) and feline calicivirus (FCV-F9) have been used as surrogates to model human norovirus behavior under laboratory conditions. The objectives of this study were to determine thermal inactivation kinetics of MNV-1 and FCV-F9 in spinach, compare first-order and Weibull models, and measure the uncertainty associated with the process. D-values were determined for viruses at 50, 56, 60, 65, and 72°C in 2-ml vials. The D-values calculated from the first-order model (50 to 72°C) ranged from 0.16 to 14.57 min for MNV-1 and 0.15 to 17.39 min for FCV-9. Using the Weibull model, the tD for MNV-1 and FCV-F9 to destroy 1 log (D ≈ 1) at the same temperatures ranged from 0.22 to 15.26 and 0.27 to 20.71 min, respectively. The z-values determined for MNV-1 were 11.66 ± 0.42°C using the Weibull model and 10.98 ± 0.58°C for the first-order model and for FCV-F9 were 10.85 ± 0.67°C and 9.89 ± 0.79°C, respectively. There was no difference in D- or z-value using the two models (P > 0.05). Relative uncertainty for dilution factor, personal counting, and test volume were 0.005, 0.0004, and ca. 0.84%, respectively. The major contribution to total uncertainty was from the model selected. Total uncertainties for FCV-F9 for the Weibull and first-order models were 3.53 to 7.56% and 11.99 to 21.01%, respectively, and for MNV-1, 3.10 to 7.01% and 13.14 to 16.94%, respectively. Novel and precise information on thermal inactivation of human norovirus surrogates in spinach was generated, enabling more reliable thermal process calculations to control noroviruses. The results of this study may be useful to the frozen food industry in designing blanching processes for spinach to inactivate or control noroviruses.Journal of food protection 02/2014; 77(2):276-83. DOI:10.4315/0362-028X.JFP-13-289 · 1.85 Impact Factor